Abstract
Dr James Campbell studied applied biology at the University of the West of England and went on to receive a PhD for a study of the utilization of glycoprotein substrates by grampositive pathogenic bacteria. James then joined a proteomics research company focusing on biomarker discovery and the development of quantitative mass spectrometry methods, before moving to The Institute of Cancer Research, London. Since then, James has worked with the next generation sequencing facility and helped set up the bioinformatic analysis pipelines for the Tumour Profiling Unit. He currently leads the Bioinformatics Facility of the ICR's Cancer Research UK Centre, supporting research groups across the institute. Lorenza Giannella (Training Manager, Biochemical Society) spoke to him about his work.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
